Kit used: Quant-iT™ RiboGreen™ RNA Assay Kit according to manufacturer's protocol.
Preparations:
Dilute TEX20 buffer to X1 with nuclease free water.
Prepare the aqueous Quant-iT™ RiboGreen® reagent working solution by diluting with TEx1- 200 fold for the high-range assay or 2,000-fold for the low-range assay.
Prepare a 2 μg/mL solution of ribosomal RNA standard (100 μg/mL) by diluting 50-fold in TEx1.
For the high-range standard curve, dilute the 2 μg/mL RNA solution as shown in Table 1. For the low-range standard curve, first dilute the 2 μg/mL RNA solution 20-fold into TEx1 to make a 100 ng/mL RNA stock solution, and then prepare the dilution series shown in Table 2.
Final RNA Concentration inQuant-iT™ RiboGreen® Assay (ng/mL)
0
1000
1000
50
500
500
1000
25
900
100
1000
5
980
20
1000
1
1000
0
1000
blank
Sample analysis
Dilute the cLNPs in TEX1 or TEX1+0.5% Triton to a final volume of 1.0 mL in eppendorfs.
Add 1.0 mL of the aqueous working solution of the Quant-iT™ Ribo Green® reagent (prepared above) to each sample. Incubate for 2 to 5 minutes at room temperature, protected from light.
Measure the fluorescence of the sample using plate reader at wavelengths 485/528.
Subtract the fluorescence value of the reagent blank from that of each of the samples.
Determine the RNA concentration of the sample from the standard curve generated in RNA Standard Curves. Compare TEx1 or TEx1+0.5% Triton diluted samples with TEx1 or TEx1+0.5% Triton diluted rRNA accordingly.
Calculate % encapsulation.
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Peer, D(2021). LNP quantification and encapsulation. Bio-protocol Preprint. bio-protocol.org/prep1024.
Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., Lieberman, J. and Peer, D.(2020). CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science Advances 6(47). DOI: 10.1126/sciadv.abc9450
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.